Abstract: A customer in a computing resource service provider environment provisions a virtual machine instance configured with access to sensitive data in a secure storage facility. The virtual machine instance is provisioned specifically to generate reports using a subset of the sensitive data to satisfy different reporting requirements associated with governing entities and agencies. After generating the reports, the virtual machine instance is then removed from the computing resource service environment such that the sensitive data is inaccessible.

Abstract: A plurality of virtual machines instances are instantiated and configured to use a subset of sensitive data to generate reports such that the reports can be visually inspected by authorized personnel or entities for potential abnormalities. After completion of the inspection, the virtual machine instances are then deleted such that the sensitive data that were used to generate the reports become inaccessible.

Abstract: Techniques for providing a network auditing service may be provided. Information about a configuration of a potentially compromised network of computer resources may be compared to a maintained and standard network configuration that is distinct from the potentially compromised network to determine differences. In one example, the potentially compromised network of computer resources may be periodically scanned for configuration information, which may be compared to the standard network configuration to determine if any changes have occurred that would indicate security problems. A report of the differences between the potentially compromised network and the standard network configuration information may be generated and provided for presentation.

Abstract: The present invention refers to a method for determining the genotype of an individual at the 5p13.1 Crohn's disease risk locus, the method comprising: providing a sample from the individual; determining whether a DNA sequence corresponding to a DNA sequence polymorphism located between coordinated 40,300,000 and 40,600,000 of human chromosome (coordinates corresponding to the march 2006 assembly of the human genome) is present in the sample; and determining the nature of the DNA sequence polymorphism genotype located between coordinated 40,300,000 and 40,600,000 of human chromosome as it relates to the genetic risk to develop Crohn's disease.

Abstract: The present invention relates to methods and compositions to evaluate or assess the response of a subject to particular therapeutic treatment. More particularly, the invention provides methods to determine the response of subjects, or to adapt the treatment protocol of subjects treated with therapeutic antibodies. The invention is based on a determination of the FCGR3A genotype of a subject. The invention can be used for patients with malignancies, particularly lymphoma, and is suited to select best responders and/or adjust treatment condition or protocol for low responders.

Abstract: There is described a device which comprises fixed means to feed forks one by one to the stacking location along a path at right angle to the transfer means movement direction between the parallel members and adjacent that edge provided with said perforations of those bags retained by said members, said forks of U-shape being free relative to one another, with legs directed at right angle to the transfer means movement direction and the leg free ends being directed towards the means allowing to release the bags from the transfer means in such a way that the fork legs enter the bag perforations, and means for moving the fork brought to the stacking location and on which will be stacked the bags to form a stack, along a direction in parallel relationship with the legs thereof to let said fork lie in two positions, the one position in which the fork is stationary to allow stacking the bags during said stacking operation and the second position in which the forks is free and can leave by gravity the device with th